Clinical Trial Update: A Clinical Trial of Chazhu Xiaozhi Decoction Against Non-alcoholic Fatty Liver Disease [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the Chazhu Xiaozhi Decoction for non-alcoholic fatty liver disease has completed, providing updated results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-alcoholic Fatty Liver Disease

Drugs mentioned

• Chazhu Xiaozhi Decoction

Snippet

Sponsor: Shanghai Municipal Hospital of Traditional Chinese Medicine | Conditions: Hepatic Steatosis, Symptoms and Signs | Phase 2 | Status: COMPLETED